Skip to NavigationSkip to content

Developing Stratified Medicine in the UK - working towards a better future

Thursday, September 22, 2011
Central London, United Kingdom

Event Type: Conference

With the decline of the blockbuster era of drugs, the industry is looking at new ways to operate and so the UK Government has pledged £50million over 5 years in innovative R&D to place UK at the forefront of molecular-based healthcare with the establishment of the Stratified Medicine Innovation Platform (SMIP) announced last October and seven projects are already up and running. Some drugs are already on the market under this principle and a growing pipeline means urgent issues from regulatory, reimbursement to the need for a new business model and forging long term partnerships need to be discussed to ensure the progress towards more targeted therapy is realised.

With this in mind, Inside Pharma are proud to present Developing Stratified Medicine in the UK – working towards a better future. This timely one-day seminar will be bringing together key stakeholders in the industry to advise on the upcoming issues and promote debate about the impacts and what can be done to ensure greater speed from bench to bedside with fewer side effects at better value.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches